Effect of IL-17i on metabolic profile and CV safety in PsA/axSpA 169 pts 12mo -IL-17i no MACE reported -CRP reduced 4.8 → 2.9 mg/L, p<0.001 -79% systemic inflammatory response -Lipids stable (LDL, TG, TC) 12mo follow up is probably too short though #POS0375 #EULAR2026 https://t.co/u6cvB5YYGq